BioRap Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioRap Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10905
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, blood coagulation, multiple sclerosis, inflammatory bowel disease, prostate cancer, chronic colitis and colitis-associated cancer, and diabetes. Its technologies are used in the therapeutic areas of oncology, neurology, cardiology, hematology, and dermatology. The company caters to biopharmaceutical, medical devices, and medical diagnostic sectors. It serves its clients in Israel and abroad. BioRap is headquartered in Haifa City, Israel.

BioRap Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Ltd – Key Competitors 14
BioRap Technologies Ltd – Key Employees 15
BioRap Technologies Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Ltd, Key Competitors 14
BioRap Technologies Ltd, Key Employees 15

List of Figures
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioRap Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mironid Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discove …
  • University College London:企業のM&A・提携動向(医療分野)
    Summary University College London (UCL) is an educational institute that provides undergraduate, post-graduate, and life learning programs. It offers programs in the areas of arts and humanities, Bartlett faculty of the built environment, brain sciences, engineering, laws, life sciences, mathematica …
  • Ted Baker PLC (TED):企業の財務・戦略的SWOT分析
    Ted Baker PLC (TED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Pharmaxis Limited (PXS):(医療機器分野)企業M&A及び提携動向
    Summary Pharmaxis Ltd. (Pharmaxis) is a pharmaceutical company. The company develops products for diagnosis and treatment of chronic respiratory and immune disorders. It offers products such as include Aridol, and Bronchitol. Pharmaxis’s Aridol is a lung function test and is to assist physicians in …
  • Aqua Logistics Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aqua Logistics Limited Mergers …
  • Athera Biotechnologies AB(製薬・医療分野):企業M&A動向
    Summary Athera Biotechnologies AB (Athera) is a biopharmaceutical company. It develops targeted anti inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease. The company has a proprietary pre IND program, PC-mAb, supported by an ap …
  • Black Rock Mining Limited (BKT):企業財務及び戦略的SWOT分析
    Summary Black Rock Mining Limited (BRML), formerly Green Rock Energy Limited is an mining company that offers exploration services. The company develops Mahenge Graphite Project, that holds the largest high-grade flake graphite resource in Tanzania. It also offers pre feasibility studies and scoping …
  • U.S. Energy Corp. (USEG):企業のM&A・提携動向(石油・ガス分野)
    Summary U.S. Energy Corp. (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas in the US. The company also offers maintenance of mineral properties. Its drilling portfolio includes Williston Basin of North Dakota and Montana; on shore Gulf …
  • AccessClosure, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary AccessClosure, Inc. (AccessClosure) is a medical device company that manufactures and distributes vascular closure devices. The company offers products like MynxGrip Vascular Closure Device, Mynx Ace Vascular Closure Device, and Flash Ostial System. Its Mynx closure devices provide patient c …
  • Beijing Tianrun New Energy Investment Co., Ltd.:企業のM&A・提携動向(発電分野)
    Summary Beijing Tianrun New Energy Investment Co., Ltd. (Tianrun New Energy), a subsidiary of Xinjiang Goldwind Science & Technology Co., Ltd., is an alternative energy company that offers wind power services. The company offers services which include consulting, planning, development, investing, fi …
  • Synthetic Genomics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Synthetic Genomics, Inc. Merger …
  • Precipio Inc (TBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services …
  • Aoxing Pharmaceutical Company, Inc. (Formerly China Aoxing Pharmaceutical Company, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aoxing Pharmaceutical Company, …
  • Godrej Consumer Products Limited:企業の戦略・SWOT・財務情報
    Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report Summary Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Marine Harvest ASA:企業の戦略・SWOT・財務分析
    SummaryMarine Harvest ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Valneva SE (VLA):企業のM&A・提携動向(医療分野)
    Summary Valneva SE (Valneva) is a biotechnology company that develops, manufactures and commercializes vaccines for the treatment of people with infectious diseases. The company’s products include IXIARO, an encephalitis vaccine and DUKORAL, which is indicated for the prevention of cholera. It vacci …
  • Microbix Biosystems Inc. (MBX):企業概要、財務及び戦略的SWOT分析
    Summary Microbix Biosystems Inc. (Microbix) is a biotechnology company. The company develops biological products and technologies. It produces infectious disease antigens for the diagnostics market. Microbix’s products include adenovirus vectors, and infectious disease antigens. The company provides …
  • Briggs & Stratton Corporation (BGG):企業財務及び戦略的SWOT分析
    Briggs & Stratton Corporation (BGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BRF SA:企業概要・SWOT・財務分析
    Summary Canadean's "BRF SA : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, comp …
  • Hoegh LNG Holdings Ltd (HLNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly Leif Hoegh & Co Ltd is an oil and gas company that offers oilfield services and floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, L …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆